Latest Press Releases
Balmes Transplantation Raises €700,000 in Seed Funding
Marseille, February 6, 2017 – Balmes Transplantation, an early stage innovative biotech company specializing in the fast development of combinations of repurposed drugs against kidney ischemia-reperfusion injury (IRI), announces today that it raised 700,000 euros in seed funding from the company’s top executives, Patrick Berna (founder and CEO) and Guillaume Demarne (CBDO), and from a group of angel investors.
Read full press release (PDF)
Throughout the year, Balmes Transplantation participates in numerous scientific and investor events around the world. Each of these activities gives us an opportunity to showcase our approach and technology, build relationships with clinicians, surgeons and financial partners, and share and gain invaluable insights.
Below are the upcoming events where Balmes Transplantation will be represented.
|4th International Meeting on Ischemia-Reperfusion Injury in Transplantation
April 19-20, 2018 – Poitiers, France
The 4th International Meeting on Ischemia Reperfusion Injuries in Transplantation is designed for clinicians and clinical investigators, research associates, basic science investigators (cell and molecular biologists), members of public and private funding organizations, hospital administrators, program directors, legislators, and regulatory agency personnel.
|19th Bio€quity Europe
May 14-16, 2018 – Ghent, Belgium
Now celebrating its 19th meeting, Bio€quity Europe is the seminal industry event for financial dealmakers looking for investor-validated life science companies positioning themselves to attract capital, and for pharmaceutical licensing professionals to assess top prospects.
|European Renal Association & European Dialysis and Transplant Association
May 24-27, 2018 – Copenhagen, Denmark
The European Renal Association – European Dialysis and Transplant Association (ERA-EDTA) is convinced that the best treatment for the individual patient can only be obtained by a joined decision between the physician and the patient. ERA-EDTA aim at providing up-to-date knowledge, exclusively based on scientific data.
|2018 BIO International Convention
June 4-7, 2018 – Boston, MA
BIO attracts 16,000+ biotechnology and pharma leaders who come together for one week of intensive networking to discover new opportunities and promising partnerships. We bring together a wide spectrum of life science and application areas including drug discovery, biomanufacturing, genomics, biofuels, nanotechnology and cell therapy.
|27th International Congress of The Transplantation Society
June 30 – July 5, 2018 – Madrid, Spain
The mission of The Transplantation Society is to provide global leadership in the practice of human transplantation. The responsibility of The Transplantation Society is to establish guidelines of clinical practice, advance programs of education, and to promote ethical standards for clinical care and scientific investigation.